The COVID-19 Pandemic Disproportionately Affects Patients with Cancer
“There were delays in getting preventative screenings, there were delay in diagnostics, there was also a brief period of time when some of the clinical trials were shut down.”
The COVID-19 pandemic has disproportionately affected patients with cancer, explained Chastity M. Washington, MPH, CHES, director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, James Cancer Hospital.
Washington presented on Cancer Health Equity in the COVID-19 Era at the 5th Annual School of Nursing Oncology. In an interview with Oncology Nursing News®, Washington provided a brief introduction to how the pandemic specifically affected different populations of patients with cancer.
Her presentation at the meeting highlighted “the impacts of the pandemic, on those disparities, on the social determinacies of health on the health care system itself, the differences we’ve seen in cancer patients with covid, the impact of some of the preventative things related to cancers, such as screenings, there were delays in getting preventative screenings, there were delay in diagnostics, there was also a brief period of time when some of the clinical trials were shut down. So, how all those things impact cancer patients in general, but then also how they have sort of an extra impact those vulnerable minority, economically disadvantaged populations that we serve.”
